PLASMA ENALAPRIL LEVELS AND HORMONAL EFFECTS AFTER SHORT-TERM AND LONG-TERM ADMINISTRATION IN ESSENTIAL-HYPERTENSION

被引：29

作者：

JOHNSTON, CI

JACKSON, BJ

LARMOUR, I

CUBELLA, R

CASLEY, D

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 18卷

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02602.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S233 / S239

页数：7

共 28 条

[1] ANTIHYPERTENSIVE THERAPY WITH MK-421 - ANGIOTENSIN-II-RENIN RELATIONSHIPS TO EVALUATE EFFICACY OF CONVERTING ENZYME BLOCKADE [J].

BIOLLAZ, J ;

BRUNNER, HR ;

GAVRAS, I ;

WAEBER, B ;

GAVRAS, H .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (06) :966-972

[2] 3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J].

BIOLLAZ, J ;

BURNIER, M ;

TURINI, GA ;

BRUNNER, DB ;

PORCHET, M ;

GOMEZ, HJ ;

JONES, KH ;

FERBER, F ;

ABRAMS, WB ;

GAVRAS, H ;

BRUNNER, HR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :665-670

[3] CLINICAL USE OF AN ORALLY ACTING CONVERTING ENZYME-INHIBITOR - CAPTOPRIL [J].

BRUNNER, HR ;

GAVRAS, H ;

WAEBER, B ;

TEXTOR, SC ;

TURINI, GA ;

WAUTERS, JP .

HYPERTENSION, 1980, 2 (04) :558-566

[4]

BRUNNER HR, 1983, HYPERTENSION, V5, P101

[5] CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS [J].

CASE, DB ;

ATLAS, SA ;

LARAGH, JH ;

SEALEY, JE ;

SULLIVAN, PA ;

MCKINSTRY, DN .

PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) :195-206

[6]

Clauser E, 1983, J Hypertens Suppl, V1, P37

[7]

GAVRAS H, 1981, LANCET, V2, P543

[8] CAPTOPRIL - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY [J].

HEEL, RC ;

BROGDEN, RN ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1980, 20 (06) :409-452

[9]

HOLLENBERG NK, 1982, CLIN EXP PHARMACOL P, P73

[10]

JACKSON B, 1982, CLIN EXP PHARMACOL P, P99

← 1 2 3 →